Spring Works Therapeutics (SWTX) PT Raised to $100 at Wedbush, Following Clinical Update

February 25, 2021 1:41 PM EST
Get Alerts SWTX Hot Sheet
Price: $86.01 -0.05%

Rating Summary:
    6 Buy, 0 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 22 | Down: 26 | New: 45
Trade Now! 
Join SI Premium – FREE

Get inside Wall Street with StreetInsider Premium. Claim your 1-week free trial here.

Wedbush analyst David Nierengarten raised the price target on Spring Works Therapeutics (NASDAQ: SWTX) to $100.00 (from $99.00) while maintaining a Outperform rating.

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In

Related Categories

Analyst PT Change